Effect of bosentan therapy in persistent pulmonary hypertension of the newborn

• প্রধান লেখক: Gunlawadee Maneenil (লেখক), Anucha Thatrimontrichai (লেখক), Waricha Janjindamai (লেখক), Supaporn Dissaneevate (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Elsevier, 2018-02-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Background: Persistent pulmonary hypertension of the newborn (PPHN) contributes to neonatal hypoxemia and is associated with a high mortality. Some PPHN patients are unresponsive to inhaled nitric oxide (iNO). Bosentan, an oral endothelin-1 receptor antagonist, reduces pulmonary vascular resistance...